Pfizer to Sell Capsugel
Capsugel will be sold for $2.375 billion in cash.
Pfizer announced plans to sell Capsugel (Peapack, NJ), the world’s leading provider of pharmaceutical and dietary supplement capsules, to private equity firm Kohlberg Kravis Roberts & Co. Capsugel will be sold for $2.375 billion in cash.
Last year, Capsugel generated approximately $750 million in revenue and manufactured more than 180 billion hard capsules. The transaction is expected to be completed this year. Capsugel will maintain its corporate presence in the United States and its global headquarters in New Jersey.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Mars partners with suppliers like ADM to bring regeneratively grown ingredients to pet food
November 25th 2024Mars (Franklin, TN) is collaborating with partners and suppliers like ADM, The Anderson, Inc., Riceland Foods, and Soil and Water Outcomes Fund through its Royal Canin USA and Petcare U.S. Inc. brands to provide financial incentives to farmers to implement regenerative agricultural practices.
